Handelsbanken Fonder
PTLA

Handelsbanken Fonder’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Handelsbanken Fonder’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,988
Closed -$324K – 1484
2020
Q2 		$324K Buy
+17,988
New +$250K ﹤0.01% 1180

Handelsbanken Fonder's PTLA Position: Q3 2020 in Review

Handelsbanken Fonder sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 17,988 shares — an estimated $324K sold.

Handelsbanken Fonder first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $324K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Handelsbanken Fonder reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Handelsbanken Fonder sold 17,988 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $324K.
  • Handelsbanken Fonder first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Handelsbanken Fonder's Portola Pharmaceuticals, Inc. position peaked at $324K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Handelsbanken Fonder's 13F filing for Q3 2020, filed 13 Nov 2020.